Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria; Department of Pharmaceutical Technology, Faculty of Pharmacy, Universitas Ahmad Dahlan, Jl. Prof. Dr. Soepomo, S.H., Janturan, Warungboto, Umbulharjo, Yogyakarta 55164, Indonesia.
Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Int J Pharm. 2022 Sep 25;625:122096. doi: 10.1016/j.ijpharm.2022.122096. Epub 2022 Aug 10.
The aim of this study was to develop phosphate decorated lipid-based nanocarriers including self-emulsifying drug delivery systems (SEDDS), solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) to extend their mucosal residence time. All nanocarriers contained tetradecyltrimethylammonium bromide (TTAB) and polyoxyethylene (9) nonylphenol monophosphate ester (PNPP) for surface decoration. Zeta potential, cytotoxicity, charge conversion and phosphate release studies using isolated intestinal alkaline phosphatase (IAP) and Caco-2 cells were performed. Moreover, the residence time of nanocarriers was determined on porcine intestinal mucosa. Results showed a shift from negative to positive zeta potential due to the addition of TTAB and charge conversion back to a negative zeta potential when also PNPP was added. Up to a concentration of 0.3 %, lipid-based nanocarriers were not toxic. Charge conversion studies with IAP revealed the highest zeta potential shift for NLC with almost Δ22 mV. Phosphate release studies using isolated IAP as well as Caco-2 cells showed a fast phosphate release for SEDDS, SLN and NLC. SLN and NLC provided the highest increase in mucosal residence time that was 4-fold more prolonged than that of blank formulations. In conclusion, phosphate modified lipid-based nanocarriers can essentially prolong the intestinal residence time of their payload.
本研究旨在开发磷酸化的基于脂质的纳米载体,包括自乳化药物递送系统(SEDDS)、固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC),以延长其粘膜停留时间。所有纳米载体均包含十四烷基三甲基溴化铵(TTAB)和聚氧乙烯(9)壬基酚单磷酸酯(PNPP)用于表面修饰。进行了zeta 电位、细胞毒性、电荷转换和使用分离的肠碱性磷酸酶(IAP)和 Caco-2 细胞的磷酸盐释放研究。此外,还在猪肠黏膜上测定了纳米载体的停留时间。结果表明,由于 TTAB 的添加,zeta 电位从负变为正,当同时添加 PNPP 时,电荷转换回负 zeta 电位。脂质基纳米载体在浓度高达 0.3%时没有毒性。使用 IAP 进行的电荷转换研究表明,NLC 的 zeta 电位变化最大,几乎为 22 mV。使用分离的 IAP 以及 Caco-2 细胞进行的磷酸盐释放研究表明,SEDDS、SLN 和 NLC 具有快速的磷酸盐释放。与空白配方相比,SLN 和 NLC 提供了最长的粘膜停留时间增加,延长了 4 倍。总之,磷酸化修饰的基于脂质的纳米载体可以从根本上延长其载药的肠道停留时间。